Because TAK165 is a specific HER2 inhibitor, which is also reported to decrease cell proliferation and inhibit the G1/S transition in leukemia cells28, we intended to evaluate whether TAK165 enhances the effect of ATRA by inhibiting HER2. Here, ERBB2 is linked to leukemia.